REFERENCES
1. Patel MR, Calhoon JH, Dehmer GJ, et al. ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2016 Appropriate Use Criteria for Coronary Revascularization in Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and the Society of Thoracic Surgeons. J Am Coll Cardiol 2017;69(5):570-591.
2. Wiviott SD, Braunwald E, McCabe CH, et al. Prasugrel versus clopidogrel in patients with acute coronary syndrome. N Engl J Med 2007;357:2001-15.
3. Schoergenhofer C, Hobl EL, Staudinger T, et al. Prasugrel in critically ill patients. Thromb Haemost 2017;117(8):1582-1587.
4. Wiviott SD, Antman EM, Braunwald E. Prasugrel. Circulation 2010;122(4):394-403.
5. Yu PJ, Cassiere HA, Dellis SL, Manetta F, Stein J, Hartman AR. P2Y12 platelet function assay for assessment of bleeding risk in coronary artery bypass grafting. J Card Surg 2014;29(3):312-6.
6. Agarwal S. Platelet function testing in cardiac surgery. Transfus Med 2016;26(5):319-329.
7. Rafiq S, Johansson PI, Kofoed KF, Olsen PS, Steinbrüchel DA. Preoperative hemostatic testing and the risk of postoperative bleeding in coronary artery bypass surgery patients. J Card Surg 2016;31(9):565-71.
8. Hansson EC, Jeppsson A. Antiplatelet Therapy, Platelet Function Testing, and Bleeding Complications in Cardiac Surgery Patients. Semin Thromb Hemost 2017;43(7):699-705.
9. Fiore M, Horovitz A, Pons AC, Leroux L, Casassus F. First report of a subacute stent thrombosis in a prasugrel resistant patient successfully managed with ticagrelor. Platelets 2014;25(8):636-8.
10. Alexopoulos D, Panagiotou A, Xanthopoulou I, et al. Antiplatelet effect of prasugrel vs. double clopidogrel in patients on hemodialysis and with high on-treatment platelet reactivity. J Thromb Haemost 2011;9:2379-2385.
11. Franken CC, Kaiser AF, Kruger JC, Overbeck K, Mügge A, Neubauer H. Cytochrome P450 2B6 and 2C9 genotype polymorphism – A possible cause of prasugrel low responsiveness. Thrombos Haemost 2013;110:131-140.
12. Price MJ, Walder JS, Baker BA, et al. Recovery of platelet function after discontinuation of prasugrel or clopidogrel maintenance dosing in aspirin-treated patients with stable coronary disease: the recovery trial. J Am Coll Cardiol 2012;59:2338-2343.
13. Li YG, Ni L, Brandt JT, Small DS, Payne CD, Ernest CS2nd, Rohatagi S, Farid NA, Jakubowski JA, Winters KJ. Inhibition of platelet aggregation with prasugrel and clopidogrel: an integrated analysis in 846 subjects. Platelets 2009;20(5):316-27.
14. Mannacio V, Meier P, Antignano A, Di Tommaso L, De Amicis V, Vosa C. Individualized strategy for clopidogrel suspension in patients undergoing off-pump coronary surgery for acute coronary syndrome: a case-control study. J Thorac Cardiovasc Surg 2014;148:1299-1306.